VVOS
VVOS
NASDAQ · Health Care

Vivos Therapeutics Inc

$1.55
+0.05 (+3.33%)
As of Feb 8, 2:27 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 4.21M 4.42M 4.57M
Net Income 767.3K 675.6K 727.9K
EPS
Profit Margin 18.3% 15.3% 15.9%
Rev Growth +6.9% +3.6% -1.9%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 6.28M 6.54M 5.85M
Total Equity 7.88M 8.58M 7.69M
D/E Ratio 0.80 0.76 0.76
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 1.16M 1.16M 1.26M
Free Cash Flow 792.1K 869.0K 665.9K